Liam Davenport April 04, 2019 GLASGOW — Combining prophylactic infusions and anti-platelet therapy normalises thrombus formation in patients with congenital thrombotic thrombocytopenic purpura (TTP) under shear flow conditions, reveals a novel assay developed by UK researchers that could revolutionise both the diagnosis and management of this rare condition. Congenital TTP is an inherited deficiency in ADAMTS13 (a disintegrin and...